The Early Efficacy of Topical Levocabastine in Patients with Allergic Conjunctivitis
Background: We investigated the early efficacy of topical levocabastine, an H1 histamine-receptor antagonist, in improving the clinical symptoms of allergic conjunctivitis. Methods: Thirty-six patients with allergic conjunctivitis were enrolled. One drop of levocabastine was instilled in one eye and...
Main Authors: | Hiroshi Fujishima, Kazumi Fukagawa, Yoji Takano, Shigeki Okamoto, Yayoi Nakagawa, Eiichi Uchio, Norihiko Yokoi, Atsuki Fukushima, Etsuko Takamura |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2006-01-01
|
Series: | Allergology International |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1323893015309801 |
Similar Items
-
Practical and Sustainable Synthesis of Optically Pure Levocabastine, a H1 Receptor Antagonist
by: Sung Kwon Kang, et al.
Published: (2017-11-01) -
Modern opportunities of therapeutic treatment of allergic conjunctivitis. A review
by: D. Yu. Maychuk
Published: (2014-07-01) -
Blood Level of Tacrolimus in Patients with Severe Allergic Conjunctivitis Treated by 0.1% Tacrolimus Ophthalmic Suspension
by: Nobuyuki Ebihara, et al.
Published: (2012-01-01) -
Epidemiological aspects of allergic conjunctivitis
by: Dai Miyazaki, et al.
Published: (2020-10-01) -
Development and validation of stability-indicating RP-HPLC method for the determination of Levocabastine HCl in bulk drug and in ophthalmic suspensions
by: Hashem AlAani, et al.
Published: (2017-05-01)